Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission
-
Sculpture Hospitality Launches Innovative Ordering Feature to Streamline Inventory Management
-
Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering
-
Latin Metals Announces Closing of Private Placement for Gross Proceeds of $2.0 Million
-
Coherent Announces Sale of UK Manufacturing Facility Following Strategic Review
-
Form 8.3 - AXA INVESTMENT MANAGERS: Rightmove plc
-
Ocean Power Technologies Ships Multiple Unmanned Surface Vehicles to US Government
-
Blink Charging Surpasses 100,000 Charger Milestone
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Alliance Trust PLC - Net Asset Value
-
StepStone Group Completes Fundraising for Fifth Private Equity Secondaries Program at $7.4 billion
-
WeightWatchers Announces Executive Leadership Transition
-
Hurco Celebrates Successful IMTS as Show Generates Excitement Over Technological Advancements
-
SEALSQ Research Receives Recognition at CRYPTOLOGY2024 for Post-Quantum Work
-
Lexicon to Present Phase 3 Trial Design for Sotagliflozin in Hypertrophic Cardiomyopathy (HCM) at Upcoming Medical Congress
-
Odyssey Trust Company named one of Canada's Top Growing Companies for the 3rd Consecutive Year
-
ACAMS Expands Advisory Board to Drive Innovation and Fortify Global Fight Against Financial Crime
-
American Rebel Light Beer is Primary Sponsor of Tony Stewart Racing Team’s SRT Hellcat Funny Car driven by Matt Hagan at the NHRA Midwest Nationals in St. Louis
-
Empire State Development Announces Round Seven Winners of Luminate NY Accelerator Competition
-
Westrock Coffee Company Announces Expiration and Results of Exchange Offer and Consent Solicitation
-
33 Medical Wins 2024 Best Technology in Spine Award for Innovative NuvoDisc® Device
-
Expanse Studios (GMGI) Ignites Industry Interest With Groundbreaking Games at SBC Summit Lisbon 2024
-
EQV Ventures Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants
-
AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment
-
Lifetime Brands Inc. Grows Commercial Food Services Business with Expansion of its Mikasa Hospitality Portfolio
-
SEALSQ Research Receives Recognition at CRYPTOLOGY2024 for Post-Quantum Work
-
ImPact Biotech Announces 50% Enrollment in Phase 3 ENLIGHTED Clinical Trial of Padeliporfin VTP in Low Grade Upper Tract Urothelial Cancer
-
TGS ASA is assigned Ba3 rating from Moody’s
-
Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed
-
Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital
-
HPQ Silica Polvere Fumed Silica Reactor: Commissioning Completed
-
Sparton Provides Further Information on the VRB Energy–Red Sun Transaction and Announces Commencement of Drilling at the Pense-Montreuil Project
-
Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules
-
Venus Concept Announces $15 million Debt-to-Equity Exchange Transaction
-
Jeffs’ Brands: Fort Products Was Selected by Amazon UK as Key Account, and Now Eligible for the Top Seller Program
-
G2 Names INE 2024 Enterprise and Small Business Leader
-
Welshare Health Introduces AI-Driven App to Inaugurate the Future of Patient-Driven Medical Research
-
Calian collaborates with Microsoft to offer scalable cloud-native cybersecurity solutions
-
Bitget Partners with Cats (CATS) for Gas-free Airdrop Claim and Launchpool Listing
-
KCEX Expands Global Crypto Trading Platform with New Reward Center and Daily Futures Trading Competitions
-
Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)
-
United Steelworkers union call out Pierre Poilievre’s misleading attack on Pharmacare
-
Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines
-
Lyra Therapeutics to Present Study Results for LYR-210 and LYR-220 in Two Presentations at the ARS and AAO-HNS Annual Meetings
-
Canadian Premium Sand Inc. Announces CFO Transition
-
Jianzhi Education Technology Group Company Limited Reports Half Year 2024 Financial Results
-
Amplify ETFs Declares September Income Distributions for its Income ETFs
-
Prison management company CoreCivic honored as inmates restore 55,000th wheelchair for people in need
-
OTC Markets Group Welcomes G Mining Ventures Corp. to OTCQX
-
Composition of Lassila & Tikanoja plc’s Nomination Board
